Publication by CIRI in The Journal of Allergy and Clinical Immunology, on April 24, 2020.
A collaborative study involving clinical teams from Hospices Civils de Lyon, several research teams from the International Research Center for Infectious Diseases - (CIRI - Inserm/CNRS/ENS de Lyon/UCBL) and the HCL-bioMérieux joint research unit has just been accepted for publication by The Journal of Allergy and Clinical Immunology, an international medical journal. It focuses on very specific proteins, Type 1 interferons, and directs us towards new therapeutic avenues for COVID-19 patients.
Source: Type I IFN immunoprofiling in COVID-19 patients. Sophie Trouillet-Assant, Sebastien Viel, PharmD, Alexandre Gaymard, Sylvie Pons, Jean-Christophe Richard, Magali Perret, Marine Villard, Karen Brengel-Pesce, Bruno Lina, Mehdi Mezidi, Laurent Bitker, Alexandre Belot, COVID HCL Study group. Journal of Allergy and Clinical Immunology, April 29, 2020